Story
TSA to Remove Chairs from Airport ID Checkpoints, Drawing Union Criticism

Summary
The Transportation Security Administration will require its officers to stand while checking IDs at US airports, a move the agency says enhances security but a major union decries as a disregard for worker safety.
The U.S. Transportation Security Administration (TSA) is removing chairs from its airport security checkpoints, requiring officers to stand while checking passenger identification documents, the agency and a major union confirmed Tuesday.
Agency Cites Security, Union Warns of Safety Risks
The TSA defended the decision as a measure to improve both security and service. "This welcome change reinforces both our security posture and our commitment to hospitality by having these officers on their feet and alert," the agency stated. It also noted that all officers must meet fitness requirements to perform their national security duties.
However, the move drew immediate criticism from the American Federation of Government Employees (AFGE) TSA Council 100, which represents the workers. The union called the policy a "disregard for workers’ rights and safety," arguing the chairs "serve as basic ergonomic and safety support for officers that stand and walk on hard surfaces all day."
AdPolicy Change Amid Agency Pressure
This operational change comes during a period of significant pressure on the agency. In April, the Trump administration proposed cutting the TSA's annual budget by $1.5 billion, or about 20%, and reducing its 60,000-person workforce by more than 9,400 employees.
The administration has also proposed requiring smaller airports to use private security screeners, a move that could cut an additional 4,500 jobs from the TSA payroll. This follows a lengthy government shutdown this spring that left 50,000 TSA workers without pay for six weeks, causing significant travel disruptions and wait times of four hours or more at some airports.
Read next
More on Stocks
Dyne Therapeutics Shares Rise on Positive 12-Month Data for DM1 Drug
The clinical-stage biotech company reported significant functional improvements in patients with myotonic dystrophy type 1 (DM1) in its Phase 1/2 ACHIEVE trial, boosting investor confidence.

Accelevation Prices IPO at $18 Per Share Ahead of Nasdaq Debut
Accelevation Holdings Corp. has priced its initial public offering of 30 million shares at $18.00 each, with the majority of shares being sold by existing stockholders. The company is set to begin trading on the Nasdaq under the ticker ACCV.

Robinhood to Introduce 24/7 Trading with Weekend Access for Select US Stocks
The online brokerage announced it will allow users to trade a selection of US stocks and ETFs around the clock on weekends, a first for the platform and part of a broader industry shift toward continuous market access.

Google Paying Publishers for AI-Generated Search Content, Report Says
Google has reportedly initiated a pilot program to pay around 100 digital publishers for content used in its AI-powered search results, a move that comes as AI features reduce referral traffic to news sites.